ArticleDiscover oncology2026
Predicting cervical cancer among women living with HIV/AIDS at public health facilities in a resource-limited setting in Ethiopia using machine learning analysis.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCervical cancer is a malignancy associated with human immunodeficiency virus, characterized by abnormal cervical cell mutations. Machine learning techniques offer valuable support for early detection and prediction of cervical cancer, potentially lowering screening and treatment costs. This study specifically targeted women living with human immunodeficiency virus, aiming to identify the most significant predictors of cervical cancer and to determine the most effective supervised machine learning model for its prediction within this population.
methodsThis study employed a multi-center, cross-sectional design using a secondary dataset from the smart care systems of four antiretroviral therapy clinics in central Debre Markos town. To determine the most relevant predictors, seven machine learning models, Logistic Regression, Random Forest, K-Nearest Neighbors, Support Vector Machine, Decision Tree, Extreme Gradient Boosting, and AdaBoost were implemented to identify the top-performing model. Model performance was assessed using the confusion matrix and the Area under the Receiver Operating Characteristic Curve.
resultsThe findings indicated that adherence at enrollment, screening visit type, and nutritional status, months on anti-retroviral therapy, follow-up status, and weight were highly important predictors of cervical cancer. Among the evaluated models, the K-Nearest Neighbors model outperformed the others, achieving the highest accuracy of 98% and an Area under the Receiver Operating Characteristic Curve of 0.68.
conclusionAs demonstrated in this study, the K-Nearest Neighbors model showed the best performance in effectively predicting cervical cancer among women living with human immunodeficiency virus. Strengthening nutritional support interventions, improving follow-up mechanisms, and enhancing anti-retroviral therapy adherence counseling programs may collectively contribute to reducing the risk of cervical cancer among women living with human immunodeficiency virus. Future research should focus on validating the predictive model across diverse geographic regions and healthcare contexts to enhance its generalizability, robustness, and practical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.